http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-33924-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_232361c9031a709144573276863c462b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-0035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-0055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J13-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-001
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 1969-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1974-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-33924-B1
titleOfInvention 11beta -chloro-19-nor-steroids
abstract 1,260,465. Compositions comprising steroids. GLAXO LABORATORIES Ltd. 23 Jan., 1969 [29 Jan., 1968], No. 4570/68. Heading A5B. [Also in Division C2] Pharmaceutical and veterinary compositions having hormonal activity, particularly progestational and anti-estrogenic activity with or without anti-androgenic activity, contain 9α- unsubstituted 11#-chloro-19-nor-steroids having the following structure in the D-ring where R<SP>1</SP> is -COCH 3 ; R<SP>2</SP> is H, OH or acyloxy; R<SP>3</SP> is OCH 3 ; or R<SP>2</SP>+R<SP>3</SP> is a carboncarbon bond or an epoxy or methylene group, or R<SP>2</SP>, R<SP>3</SP> and the adjacent C atom form a 1'-pyrazolino-(4', 3':16α, 17α)- or 2'-pyrazolino-(4', 5':16α, 17α)-grouping; and R<SP>4</SP> is H or CH 3 but is not CH 3 when 16, 17-methylene or -pyrazolino is present, and, optionally, further compounds possessing hormonal activity, particularly estrogens. Oral tablets containing 17α-acetoxy-11#-chloro-16-methylene-19-nor-pregn-4-ene-3, 20-dione and ethynyl estradiol are among the specified compositions, which may be used inter alia, as contraceptives.n[GB1260465A]
priorityDate 1968-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991

Total number of triples: 23.